Susquehanna International Group, LLP Astrazeneca PLC Put Options Transaction History

Susquehanna International Group, LLP

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$76.67 - $87.62 $6.95 Million - $7.94 Million	90,600 Added 22.26%	497,600 $38.8 Million
Q2 2024 Aug 15, 2024	SELL	$66.81 - $80.83 $61.8 Million - $74.8 Million	-925,000 Reduced 69.44%	407,000 $31.7 Million
Q1 2024 May 07, 2024	BUY	$61.03 - $69.57 $15.7 Million - $17.9 Million	257,600 Added 23.98%	1,332,000 $90.2 Million
Q4 2023 Feb 14, 2024	SELL	$61.89 - $69.28 $3.31 Million - $3.71 Million	-53,500 Reduced 4.74%	1,074,400 $72.4 Million
Q3 2023 Nov 14, 2023	SELL	$64.85 - $71.7 $82.9 Million - $91.7 Million	-1,278,300 Reduced 53.13%	1,127,900 $76.4 Million
Q2 2023 Aug 11, 2023	BUY	$69.91 - $75.81 $82.6 Million - $89.5 Million	1,181,200 Added 96.42%	2,406,200 $172 Million
Q1 2023 May 16, 2023	SELL	$63.15 - $71.6 $17.8 Million - $20.2 Million	-281,900 Reduced 18.71%	1,225,000 $85 Million
Q4 2022 Feb 14, 2023	BUY	$54.21 - $70.44 $13.4 Million - $17.4 Million	247,200 Added 19.62%	1,506,900 $102 Million
Q3 2022 Nov 14, 2022	BUY	$53.02 - $135.75 $18.7 Million - $47.9 Million	352,700 Added 38.89%	1,259,700 $69.2 Million

1,359

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $203B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.